C1431T Variant of PPARγ Is Associated with Preeclampsia in Pregnant Women.

PPARγ SNPs machine learning models preeclampsia

Journal

Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444

Informations de publication

Date de publication:
07 Oct 2021
Historique:
received: 13 08 2021
revised: 01 10 2021
accepted: 02 10 2021
entrez: 23 10 2021
pubmed: 24 10 2021
medline: 24 10 2021
Statut: epublish

Résumé

Peroxisome proliferator-activated receptor γ (PPARγ) is essential for placental development, whose SNPs have shown increased susceptibility to pregnancy-related diseases, such as preeclampsia. Our aim was to investigate the association between preeclampsia and three PPARγ SNPs (Pro12Ala, C1431T, and C681G), which together with nine clinical factors were used to build a pragmatic model for preeclampsia prediction. Data were collected from 1648 women from the EDEN cohort, of which 35 women had preeclamptic pregnancies, and the remaining 1613 women had normal pregnancies. Univariate analysis comparing preeclamptic patients to the control resulted in the SNP C1431T being the only factor significantly associated with preeclampsia (

Identifiants

pubmed: 34685423
pii: life11101052
doi: 10.3390/life11101052
pmc: PMC8540421
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : China Scholarship Council
ID : 201806270256
Organisme : Campus France
ID : 969976G
Organisme : the European Union FP7 Programme
ID : FP7/2007-2013

Références

Ultrasound Obstet Gynecol. 2017 Jun;49(6):756-760
pubmed: 28295782
Prenat Diagn. 2011 Oct;31(10):990-4
pubmed: 21744367
Endocrine. 2018 Jun;60(3):466-478
pubmed: 29679223
Hum Mol Genet. 1998 Mar;7(3):435-40
pubmed: 9467001
BMC Pregnancy Childbirth. 2018 Aug 15;18(1):333
pubmed: 30111303
Metabolomics. 2017 Jan;13(1):
pubmed: 28596717
Circulation. 2012 Feb 21;125(7):911-9
pubmed: 22261192
J Clin Invest. 2007 Mar;117(3):812-22
pubmed: 17304352
Diabetologia. 2005 Aug;48(8):1496-502
pubmed: 16007414
Am J Obstet Gynecol. 2015 Oct;213(4):530.e1-530.e10
pubmed: 26116099
J Clin Endocrinol Metab. 1999 Oct;84(10):3708-12
pubmed: 10523018
Am J Obstet Gynecol. 2016 Jan;214(1):103.e1-103.e12
pubmed: 26297382
BMC Res Notes. 2020 Mar 27;13(1):181
pubmed: 32216842
Hypertension. 2011 Aug;58(2):280-6
pubmed: 21690483
Hypertension. 2011 Nov;58(5):882-7
pubmed: 21931072
Arch Endocrinol Metab. 2015 Aug;59(4):297-302
pubmed: 26331316
Am J Obstet Gynecol. 2020 Sep 28;:
pubmed: 33002498
Hypertension. 2018 Feb;71(2):306-316
pubmed: 29229743
Int J Mol Sci. 2021 Jan 04;22(1):
pubmed: 33406768
PLoS One. 2019 Aug 23;14(8):e0221202
pubmed: 31442238
Obstet Gynecol. 2009 Jun;113(6):1299-1306
pubmed: 19461426
PLoS One. 2017 Jul 20;12(7):e0181644
pubmed: 28727849
J Biomed Inform. 2002 Oct-Dec;35(5-6):352-9
pubmed: 12968784
BJOG. 2021 Jan;128(1):55-65
pubmed: 32741103
Clin Sci (Lond). 2004 Nov;107(5):461-6
pubmed: 15217350
Sci Rep. 2017 Nov 23;7(1):16189
pubmed: 29170520
Nitric Oxide. 2021 May 1;109-110:20-25
pubmed: 33676021
Oncotarget. 2017 Aug 10;8(59):100558-100569
pubmed: 29246001
Wien Klin Wochenschr. 2012 Oct;124(19-20):671-7
pubmed: 22987045
Ultrasound Obstet Gynecol. 2017 Jun;49(6):751-755
pubmed: 28067011
EBioMedicine. 2020 Apr;54:102710
pubmed: 32283530
Cardiovasc Res. 1999 Dec;44(3):588-94
pubmed: 10690291
J Clin Endocrinol Metab. 2011 Oct;96(10):E1656-60
pubmed: 21795447
BMC Genet. 2002 Nov 13;3:21
pubmed: 12429071
Bioinformatics. 2012 Jan 1;28(1):112-8
pubmed: 22039212
Diabetes Res Clin Pract. 2012 Sep;97(3):483-91
pubmed: 22515931
Front Chem. 2018 Aug 28;6:362
pubmed: 30271769
Obstet Gynecol. 2015 Sep;126(3):e25-e27
pubmed: 26287789
Lancet. 2010 May 8;375(9726):1609-23
pubmed: 20382417
J Matern Fetal Neonatal Med. 2008 Jan;21(1):9-23
pubmed: 18175241
Hypertension. 2018 Aug;72(2):408-416
pubmed: 29967039
Obstet Gynecol. 2019 Jan;133(1):1
pubmed: 30575668
Mol Cell. 1999 Oct;4(4):585-95
pubmed: 10549290
Diabetes. 1998 Nov;47(11):1806-8
pubmed: 9792554
Trends Endocrinol Metab. 2017 Jan;28(1):73-84
pubmed: 27789100
Am J Clin Nutr. 2020 Jun 1;111(6):1235-1243
pubmed: 32108865
Syst Biol Reprod Med. 2015 Apr;61(2):65-71
pubmed: 25475254
Nat Genet. 2017 Aug;49(8):1255-1260
pubmed: 28628106
Am J Obstet Gynecol MFM. 2021 Jan;3(1):100250
pubmed: 33451620
Pregnancy Hypertens. 2018 Jul;13:100-106
pubmed: 30177034
Obstet Gynecol. 2013 Nov;122(5):1122-1131
pubmed: 24150027
Front Oncol. 2019 Feb 19;9:63
pubmed: 30838172
Clin Transl Sci. 2010 Aug;3(4):147-57
pubmed: 20718815
Nat Genet. 1998 Nov;20(3):284-7
pubmed: 9806549
Future Cardiol. 2010 Sep;6(5):657-91
pubmed: 20932114
Nat Genet. 2000 Sep;26(1):76-80
pubmed: 10973253
J Clin Med. 2021 Jun 16;10(12):
pubmed: 34208487
Early Hum Dev. 2002 Oct;69(1-2):77-82
pubmed: 12324185
Int J Epidemiol. 2016 Apr;45(2):353-63
pubmed: 26283636

Auteurs

Fulin Liu (F)

Pathophysiology & Pharmacotoxicology of the Human Placenta, Pre & Postnatal Microbiota, 3PHM, INSERM, Université de Paris, F-75006 Paris, France.

Christine Rouault (C)

Nutrition et Obesités: Approches Systémiques Research Unit, INSERM, Sorbonne Université, F-75013 Paris, France.

Karine Clément (K)

Nutrition et Obesités: Approches Systémiques Research Unit, INSERM, Sorbonne Université, F-75013 Paris, France.
Nutrition Department, Pitié-Salpêtrière Hospital, Assistance Publique Hôpitaux de Paris, F-75013 Paris, France.

Wencan Zhu (W)

UMR MIA-Paris, INRAE, AgroParisTech, Université Paris-Saclay, F-75005 Paris, France.

Séverine A Degrelle (SA)

Pathophysiology & Pharmacotoxicology of the Human Placenta, Pre & Postnatal Microbiota, 3PHM, INSERM, Université de Paris, F-75006 Paris, France.
Inovarion, F-75005 Paris, France.

Marie-Aline Charles (MA)

Centre for Research in Epidemiology and Statistics (CRESS), INSERM, INRAE, Université de Paris, F-75004 Paris, France.
Ined, Unité Mixte Inserm-Ined-EFS ELFE, F-75020 Paris, France.

Barbara Heude (B)

Centre for Research in Epidemiology and Statistics (CRESS), INSERM, INRAE, Université de Paris, F-75004 Paris, France.

Thierry Fournier (T)

Pathophysiology & Pharmacotoxicology of the Human Placenta, Pre & Postnatal Microbiota, 3PHM, INSERM, Université de Paris, F-75006 Paris, France.

Classifications MeSH